Tamarack Advisers’s NxStage Medical Inc. NXTM Stock Holding History

Tamarack Advisers’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-625,000	Closed	-$17.9M	–	28
2018 Q4	$17.9M	Buy	625,000 +25,000	+4%	+$710K	7.29%	6
2018 Q3	$16.7M	Buy	600,000 +129,463	+28%	+$3.64M	4.78%	8
2018 Q2	$13.1M	Buy	470,537 +102,277	+28%	+$2.74M	4.39%	10
2018 Q1	$9.15M	Buy	368,260 +93,260	+34%	+$2.27M	4.35%	10
2017 Q4	$6.66M	Buy	+275,000	New	+$7.25M	3.64%	10
2017 Q3	–	Sell	-127,500	Closed	-$3.2M	–	45
2017 Q2	$3.2M	Buy	127,500 +17,500	+16%	+$433K	1.87%	21
2017 Q1	$2.95M	Sell	110,000 -257,690	-70%	-$7.12M	1.84%	21
2016 Q4	$9.64M	Sell	367,690 -707,310	-66%	-$17.5M	6.82%	2
2016 Q3	$26.6M	Sell	1,075,000 -125,000	-10%	-$2.91M	8.37%	2
2016 Q2	$26M	Sell	1,200,000 -500,000	-29%	-$8.92M	9.98%	2
2016 Q1	$25.5M	Sell	1,700,000 -225,000	-12%	-$3.77M	8.92%	4
2015 Q4	$42.2M	Buy	+1,925,000	New	+$35.9M	5.55%	6

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Tamarack Advisers's NXTM Position: Q1 2019 in Review

Tamarack Advisers sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 625,000 shares — an estimated $17.9M sold.

Tamarack Advisers first reported a position in NXTM in Q4 2015 and held it in 12 quarters. The position peaked at $42.2M in Q4 2015. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Tamarack Advisers reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Tamarack Advisers sold 625,000 NxStage Medical Inc. shares in Q1 2019, an estimated $17.9M.
Tamarack Advisers first reported a position in NxStage Medical Inc. in Q4 2015 and held it in 12 quarters.
Tamarack Advisers's NxStage Medical Inc. position peaked at $42.2M in Q4 2015.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Tamarack Advisers's 13F filing for Q1 2019, filed 13 May 2019.